Navigation Links
Leatt Corporation To Sponsor 2008 South African Motocross Grand Prix
Date:7/17/2008

Race Series Titled 2008 Leatt-Brace(TM) SA MX Grand Prix

CAPE TOWN, South Africa, July 17 /PRNewswire-FirstCall/ -- Leatt Corporation (Pink Sheets: LEAT), a Nevada, USA Corporation headquartered in Cape Town, South Africa, and the distributor of the Leatt-Brace(TM), a Neck Brace System designed to help prevent potentially devastating motor sport injuries to the cervical spine (neck), today announced that the Company will become the Title Sponsor to the South African Leg of the 2008 FIM World Grand Prix Motocross Series.

Along with the title of Event sponsor, Leatt will be featured on the event posters distributed to motorcycle outlets, shopping centers and Computicket outlets. Additionally there will be a 30 second Cinema commercial produced as a Grand Prix Commercial. Official shirts and various event-related souvenirs with the Leatt 2008 logo will be marketed throughout the event. This event will be televised through numerous networks including the following: Fox Sports World, AB Moteurs, Roi Due, Speed, Vrt, Eurosports Asfa Pacific, Fox Sports, CI, Sport Satelite, SNTV, SPRTV, Eurosport, Band Sports, Eurovision, America One Sports, TVe, Galaxie Sport, Eurosport 2, Gaora Sports.

The South African venue for the race will be at the Alkmaar Motocross circuit in Nelspruit, South Africa. Approximately 15,000 spectators are expected to be in attendance and the event will be broadcast on 24 channels worldwide. The Company also expects that the race will receive extensive pre-event coverage including radio advertisements on local South African Radio Stations as well as television inserts. The FIM Motorcross World Championship reached a massive television audience in 2007; with more than 694 million viewers worldwide.

"We are extremely excited about this sponsorship and the exposure that this event will provide for the Company," said Mr. Jeff Guzy, President of the Company, "This sponsorship opportunity further validates and provides a great testimonial to the quality and reliability of the Leatt-Brace(TM) product and its importance to the Motocross community."

Motorsport South Africa (MSA) is recognised by both the Federation Internationale de l'Automobile (FIA) and the Federation Internationale de Motocyclism (FIM), as the sole national motorsport federation in South Africa. The FIM and FIA recognise only one "National" federation in each country, with such federation in turn being responsible for the control and administration of motorsport in its own country. In South Africa, the FIA and FIM have transferred their sporting powers to MSA and all motorsport events in the country are held in accordance with FIA and FIM Sporting Codes. MSA is one of only a few federations responsible for the control of both car and motorcycle sporting events, with most other countries having separate governing bodies for the two disciplines.

About Leatt Corporation:

Leatt Corporation is the exclusive global distributor of the Leatt-Brace(TM), a Neck Brace designed to prevent or lessen the severity of potentially devastating motor sport injuries to the cervical spine (neck). The company's operations and research and development of the core products currently take place at Leatt Corporation's offices in Cape Town, South Africa.

For more information on the Leatt-Brace(TM), please visit the company website at http://www.leatt-brace.com. Any web site or portion thereof referenced herein is not a part of this press release.

Safe Harbor Statement

This release may contain certain "forward-looking statements" relating to the business of Leatt Corporation and its subsidiary companies (collectively, the "Company"). All statements, other than statements of historical fact included herein are "forward-looking statements," including statements regarding: the ability of the Company to meet the requirements for or obtain approval for quotation of the Company's common stock on a national securities exchange or quotation system, or otherwise achieve its commercial objectives; the business strategy, plans and objectives of the Company; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects," "anticipates," "seeks," "intends," or "projects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, they do involve assumptions, risks and uncertainties, many of which are beyond the Company's control or ability to predict, and these expectations may prove to be incorrect or vary significantly from actual results. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Investor Relations:

Please contact Tim Clemensen at tclemensen@rubensteinir.com or call at +1 (212) 843 9337


'/>"/>
SOURCE Leatt Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Medicine Corporation Obtains Australian Patent for rADTZ
2. BioElectronics Corporations Commercial Resumes on Bloomberg Television
3. Carnegie Corporation funds ASCB course on parasites for African scientists
4. Posit Science Corporation Releases the Brain Fitness Program Classic(TM) for Mac OS X
5. Conrad A. Conrad Elected Chairman of the Board for Rural/Metro Corporation
6. CRH Medical Corporation opens center in New Orleans, Louisiana
7. Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement
8. Bederra Corporation Retains OTC Financial Network for Investor Relations
9. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
10. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
11. Chem Rx Corporation Surpasses 67,000 Beds Served
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... ... The Journal of Pain Research has published the commentary “ Terminology of ... Dr John F. Peppin says “Terminology matters, yet little attention has been paid to ... cancer pain’ and ‘chronic non-cancer pain’ are replete in the literature; however, the distinction ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... The guide will ensure lab personnel have a basic understanding of the techniques ... measurement protocols. Enhanced understanding will help them reduce waste and rework to create ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... cleaning and sealing company , is proud to announce that many of their ... levels of customer service. The hard surface restoration franchises received customer recognition through ...
(Date:2/8/2016)... PLAINSBORO, N.J. (PRWEB) , ... February 08, 2016 , ... ... on cancer patients, has officially launched the Multiple Myeloma Heroes Awards event , ... (MM) or in the lives of patients with MM. The MM Heroes Awards ...
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie ... celebrates the beginning of a new charity campaign. As part of their ongoing ... Advocates (CASA). In the belief that children deserve a voice, and in the ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Feb. 9, 2016  Landauer, Inc. (NYSE: LDR ... measurement and monitoring, outsourced medical physics services and high ... its fiscal 2016 first quarter ended December 31, 2015. ... Fiscal 2016 First Quarter Highlights , Revenue of ... quarter of 2015 , Domestic Radiation Measurement services revenues ...
(Date:2/9/2016)... , February 9, 2016 ... QIA) gab heute den Abschluss eines Kooperationsvertrags ... Förderung umfassender Lösungen in den Bereichen Next-Generation-Sequencing ... QGEN ; Frankfurt Prime Standard: QIA) ... 10x Genomics für die Entwicklung und Förderung ...
(Date:2/9/2016)... Feb. 9, 2016 Mast Therapeutics, Inc. ... for sickle cell disease and heart failure, today announced that ... to purchase common stock in an underwritten public offering.  The ... can be no assurance as to whether or when the ... or terms of the offering.   --> ...
Breaking Medicine Technology: